| 发明名称 |
POLYMORPHIC FORM OF 1-(4-{1-[(E)-4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO]-ETHYL}-2-ETHYL-BENZYL) -AZETIDINE-3-CARBOXYLIC ACID |
| 摘要 |
<p>This invention relates to a novel crystalline form (Form A) of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this crystalline form, to processes for forming it and to its use in medical treatment.</p> |
| 申请公布号 |
EP2379498(B1) |
申请公布日期 |
2015.01.21 |
| 申请号 |
EP20090793423 |
申请日期 |
2009.12.17 |
| 申请人 |
NOVARTIS AG |
发明人 |
LIU, YUGANG;PAPOUTSAKIS, DIMITRIS;RODDY, ELIZABETH |
| 分类号 |
C07D205/04;A61K31/397;A61P21/00;A61P29/00;A61P31/06;A61P31/08 |
主分类号 |
C07D205/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
